▁British 8.5703125
▁Bi 8.046875
ote 1.810546875
ch 0.12213134765625
' 5.16796875
s 0.0084686279296875
▁Can 5.8984375
cer 0.0411376953125
▁D 1.4365234375
rug 0.01163482666015625
▁Sh 3.03515625
ows 0.0587158203125
▁Pos 2.533203125
itive 0.005401611328125
▁Results 0.75439453125
▁but 7.37890625
▁Anal 5.18359375
yst 0.0034580230712890625
s 0.1402587890625
▁Ur 4.796875
ge 0.0105438232421875
▁Ca 0.181640625
ution 0.0002014636993408203
▁▁ 14.046875
<0x0A> 0.132568359375
<0x0A> 5.640625
Bi 8.515625
ote 0.20654296875
ch 0.348876953125
▁startup 5.171875
▁On 4.2890625
co 0.58935546875
Sol 7.11328125
utions 1.228515625
▁today 3.62890625
▁announced 0.7587890625
▁positive 1.0048828125
▁results 0.43603515625
▁from 0.40966796875
▁a 0.7763671875
▁Ph 0.75439453125
ase 0.0018243789672851562
▁ 1.2060546875
2 1.1708984375
▁trial 1.3857421875
▁of 0.34130859375
▁its 0.276123046875
▁experimental 2.623046875
▁cancer 0.7099609375
▁drug 0.2469482421875
▁OS 4.1953125
C 4.08984375
- 0.484130859375
4 2.7734375
3 3.265625
. 2.685546875
▁The 0.9296875
▁drug 1.2119140625
▁showed 2.615234375
▁tum 6.62109375
or 0.177001953125
▁shr 0.59619140625
ink 0.0226898193359375
age 0.003940582275390625
▁in 0.2578125
▁ 0.53662109375
6 2.2890625
5 2.380859375
% 0.84521484375
▁of 0.01824951171875
▁patients 0.5537109375
▁with 0.974609375
▁advanced 1.0244140625
▁pan 2.552734375
cre 0.00026488304138183594
atic 0.01331329345703125
▁cancer 0.1304931640625
, 1.1025390625
▁a 2.640625
▁dead 4.109375
ly 0.0099334716796875
▁disease 0.6083984375
▁with 0.88916015625
▁few 1.4228515625
▁treatment 0.73486328125
▁options 0.0087127685546875
. 0.1947021484375
▁However 3.13671875
, 0.023040771484375
▁industry 4.51171875
▁anal 0.441162109375
yst 0.0008177757263183594
s 0.027008056640625
▁war 2.607421875
ned 0.0009160041809082031
▁that 0.32958984375
▁the 0.68798828125
▁results 1.00390625
, 3.2578125
▁while 0.62841796875
▁encourag 1.1083984375
ing 0.00014650821685791016
, 0.0114898681640625
▁require 5.1328125
▁further 0.68798828125
▁validation 1.8779296875
▁before 1.7646484375
▁determ 6.23828125
ining 0.0036449432373046875
▁the 1.353515625
▁drug 0.34228515625
' 0.2054443359375
s 9.298324584960938e-05
▁potential 1.9150390625
. 0.63623046875
▁▁ 3.83203125
<0x0A> 0.0123138427734375
<0x0A> 0.26806640625
In 3.916015625
▁the 0.7314453125
▁trial 1.1806640625
▁of 3.046875
▁ 0.1419677734375
4 1.9326171875
7 2.55078125
▁patients 0.129150390625
, 0.4169921875
▁OS 1.8662109375
C 0.001361846923828125
- 0.004673004150390625
4 0.0011968612670898438
3 0.0010890960693359375
▁stopped 6.00390625
▁tum 1.0810546875
or 0.041961669921875
▁growth 0.08935546875
▁for 3.451171875
▁a 2.4140625
▁median 0.092041015625
▁of 0.156494140625
▁ 0.25537109375
4 2.212890625
. 0.351806640625
2 2.1875
▁months 0.0386962890625
. 1.2392578125
▁ 3.7421875
3 2.17578125
0 2.1640625
▁patients 2.060546875
, 2.16796875
▁or 0.1756591796875
▁ 0.1480712890625
6 0.03289794921875
5 0.330810546875
%, 0.2052001953125
▁showed 1.5869140625
▁a 1.802734375
▁reduction 1.5546875
▁in 0.1295166015625
▁tum 0.351806640625
or 0.041046142578125
▁size 0.1612548828125
▁of 2.54296875
▁at 0.5048828125
▁least 0.0004563331604003906
▁ 0.0367431640625
3 1.05078125
0 0.04541015625
%. 0.84814453125
▁On 4.57421875
co 0.41748046875
Sol 0.00554656982421875
utions 0.0083770751953125
▁CE 3.4609375
O 0.0002830028533935547
▁Jane 7.14453125
▁Smith 5.09765625
▁said 0.58935546875
, 2.013671875
▁" 0.11810302734375
We 1.1787109375
▁are 0.61376953125
▁thr 2.28125
illed 2.7298927307128906e-05
▁with 0.576171875
▁these 0.8076171875
▁results 0.238037109375
▁for 5.71875
▁a 2.59375
▁disease 2.171875
▁that 1.1904296875
▁usually 4.84375
▁has 0.56884765625
▁a 0.96923828125
▁very 1.4716796875
▁poor 0.449951171875
▁pro 0.11981201171875
gn 0.00023674964904785156
osis 0.0002218484878540039
. 1.0234375
▁OS 2.65234375
C 0.0008697509765625
- 0.005992889404296875
4 0.001224517822265625
3 0.00029158592224121094
▁could 4.0703125
▁be 1.017578125
▁a 0.4404296875
▁much 3.419921875
- 0.501953125
ne 0.005130767822265625
eded 4.744529724121094e-05
▁new 0.8427734375
▁treatment 0.437744140625
▁option 0.333740234375
▁for 0.076904296875
▁pan 0.96826171875
cre 7.736682891845703e-05
atic 0.0028896331787109375
▁cancer 0.0061187744140625
▁patients 0.1593017578125
." 0.203857421875
▁The 3.962890625
▁company 1.2509765625
▁a 5.1875
ims 0.00780487060546875
▁to 0.0120849609375
▁move 4.25
▁the 0.75048828125
▁drug 0.03631591796875
▁into 0.259521484375
▁a 1.560546875
▁larger 1.2900390625
▁Ph 0.265380859375
ase 0.00010251998901367188
▁ 0.032623291015625
3 0.031036376953125
▁trial 0.1568603515625
▁next 2.1953125
▁year 0.0095062255859375
. 0.28466796875
▁▁ 0.6943359375
<0x0A> 0.004146575927734375
<0x0A> 0.0260467529296875
Pan 4.0859375
cre 0.0005354881286621094
atic 0.0017690658569335938
▁cancer 0.00992584228515625
▁is 0.1259765625
▁the 1.74609375
▁fourth 1.30859375
▁leading 1.158203125
▁cause 0.00916290283203125
▁of 0.00030684471130371094
▁cancer 0.0140838623046875
▁death 0.2100830078125
s 1.96484375
▁world 2.439453125
wide 0.0006575584411621094
, 0.468505859375
▁with 0.50439453125
▁a 1.3935546875
▁five 0.47412109375
- 0.006404876708984375
year 0.0001780986785888672
▁surv 0.01259613037109375
ival 0.0001481771469116211
▁rate 0.0021991729736328125
▁of 0.058563232421875
▁just 0.88232421875
▁ 0.02630615234375
9 1.41796875
%. 0.116455078125
▁Ex 4.4453125
isting 0.0487060546875
▁treat 0.369873046875
ments 6.663799285888672e-05
▁are 1.58203125
▁limited 1.302734375
, 1.52734375
▁creating 8.625
▁a 0.286376953125
▁" 6.17578125
high 1.384765625
▁un 0.104736328125
met 7.092952728271484e-05
▁need 1.111328125
" 0.1910400390625
▁that 5.41015625
▁new 5.3828125
▁dru 0.70166015625
gs 4.0531158447265625e-06
▁like 1.677734375
▁OS 0.00887298583984375
C 0.00018465518951416016
- 0.0012235641479492188
4 0.0005388259887695312
3 0.0002932548522949219
▁aim 3.138671875
▁to 0.00041174888610839844
▁address 0.9189453125
. 0.147216796875
▁However 1.796875
, 0.0007944107055664062
▁anal 2.568359375
yst 0.00022172927856445312
s 0.048370361328125
▁war 2.134765625
ned 0.0001628398895263672
▁invest 6.34765625
ors 0.0002155303955078125
▁not 1.853515625
▁to 0.0005731582641601562
▁get 0.1419677734375
▁ahead 2.98828125
▁of 0.0003802776336669922
▁themselves 0.01425933837890625
▁based 5.4375
▁on 0.020263671875
▁a 4.05078125
▁single 0.83837890625
▁Ph 1.314453125
ase 6.794929504394531e-05
▁ 0.0020904541015625
2 0.0009918212890625
▁study 2.5390625
. 0.1268310546875
▁ 2.978515625
<0x0A> 0.467529296875
<0x0A> 0.052154541015625
" 1.455078125
The 2.048828125
▁data 2.24609375
▁looks 3.0078125
▁good 1.83984375
▁so 4.25
▁far 0.0009965896606445312
▁but 2.72265625
▁it 1.525390625
' 0.53515625
s 0.01049041748046875
▁still 1.5556640625
▁very 3.05859375
▁early 0.08453369140625
▁days 0.75927734375
," 0.432373046875
▁said 0.159423828125
▁David 4.1640625
▁Jones 3.64453125
, 0.7587890625
▁an 0.95947265625
▁on 2.763671875
colog 1.8720703125
ist 0.008636474609375
▁and 1.7060546875
▁man 4.91796875
aging 5.1975250244140625e-05
▁director 0.24267578125
▁at 0.59912109375
▁bi 4.9140625
ote 0.123291015625
ch 0.0286712646484375
▁invest 1.2255859375
ment 0.11590576171875
▁bank 2.1640625
▁Al 5.62890625
pha 0.9345703125
B 3.037109375
io 0.34326171875
▁Part 2.9453125
ners 0.0005817413330078125
. 0.047393798828125
▁" 0.17431640625
Ph 4.11328125
ase 0.0035228729248046875
▁ 0.002918243408203125
2 0.5537109375
▁studies 1.689453125
▁are 0.69384765625
▁designed 3.1171875
▁to 0.03216552734375
▁show 1.4765625
▁if 3.564453125
▁a 0.422119140625
▁drug 0.1820068359375
▁works 1.591796875
, 1.046875
▁but 0.904296875
▁larger 5.96875
▁tri 1.072265625
als 7.152557373046875e-07
▁are 0.2291259765625
▁needed 0.1397705078125
▁to 0.032623291015625
▁confirm 1.416015625
▁effic 2.6953125
acy 6.151199340820312e-05
▁and 0.255126953125
▁determine 1.783203125
▁long 5.296875
- 0.00720977783203125
term 0.0004963874816894531
▁benefits 3.115234375
. 2.34765625
▁Many 5.24609375
▁once 9.59375
- 0.140625
prom 0.01343536376953125
ising 0.0004832744598388672
▁treat 3.0703125
ments 2.944469451904297e-05
▁have 0.370849609375
▁st 4.06640625
umbled 2.380859375
▁in 0.89453125
▁Ph 1.0888671875
ase 0.0012149810791015625
▁ 0.001697540283203125
3 0.03192138671875
." 2.19921875
▁Jones 3.703125
▁estimates 6.484375
▁OS 3.6328125
C 0.0005373954772949219
- 0.0042877197265625
4 0.0007443428039550781
3 0.0008921623229980469
▁has 2.6796875
▁a 0.218994140625
▁ 0.32763671875
3 2.25390625
0 0.1278076171875
- 1.841796875
5 1.0361328125
0 0.0002846717834472656
% 0.003231048583984375
▁chance 0.0301971435546875
▁of 0.00994873046875
▁eventually 4.52734375
▁being 1.9638671875
▁approved 0.03277587890625
. 1.44140625
<0x0A> 1.861328125
<0x0A> 0.0936279296875
On 1.904296875
co 0.0211181640625
Sol 0.0010347366333007812
utions 0.0015916824340820312
▁will 4.984375
▁expand 8.2734375
▁its 1.0166015625
▁Ph 1.232421875
ase 0.0003399848937988281
▁ 0.0017766952514648438
3 1.740234375
▁trial 0.44580078125
▁from 4.4296875
▁ 0.65625
2 1.3505859375
0 0.80615234375
0 0.0867919921875
▁to 0.8564453125
▁ 0.0584716796875
6 2.482421875
0 0.04888916015625
0 0.000518798828125
▁patients 0.0809326171875
▁across 5.4921875
▁multiple 3.044921875
▁countries 1.3466796875
. 0.79443359375
▁" 4.29296875
This 2.453125
▁will 1.7109375
▁reduce 6.24609375
▁the 0.431396484375
▁chance 2.396484375
▁of 0.190185546875
▁an 3.974609375
▁anom 5.30078125
alous 1.03125
▁result 0.64599609375
▁and 1.8076171875
▁ensure 3.951171875
▁the 1.408203125
▁find 3.4296875
ings 3.325939178466797e-05
▁hold 3.228515625
▁up 0.08056640625
," 1.1474609375
▁Smith 4.625
▁said 0.1861572265625
. 0.04376220703125
▁The 1.92578125
▁company 0.265869140625
▁hopes 3.193359375
▁to 0.167724609375
▁submit 2.298828125
▁OS 2.173828125
C 0.00021922588348388672
- 0.0011110305786132812
4 0.0006794929504394531
3 0.0003681182861328125
▁for 0.335205078125
▁regul 0.94189453125
atory 0.0005731582641601562
▁appro 0.054351806640625
val 8.225440979003906e-06
▁in 0.7177734375
▁ 0.388671875
2 0.0050506591796875
0 0.00156402587890625
2 0.09442138671875
3 2.265625
▁if 3.818359375
▁the 0.412841796875
▁larger 3.154296875
▁trial 0.295654296875
▁confir 1.6083984375
ms 4.9114227294921875e-05
▁the 0.485595703125
▁Ph 1.1796875
ase 0.0001245737075805664
▁ 0.0013570785522460938
2 0.00141143798828125
▁out 6.4296875
comes 0.0015869140625
. 0.0216522216796875
<0x0A> 0.8701171875
<0x0A> 0.11883544921875
Wh 3.89453125
ile 0.0028228759765625
▁the 1.169921875
▁On 6.9765625
co 0.035400390625
Sol 0.00414276123046875
utions 0.0074005126953125
▁results 2.224609375
▁are 0.45361328125
▁an 5.19140625
▁encourag 0.334716796875
ing 0.0001329183578491211
▁sign 1.0986328125
▁of 3.48046875
▁progress 0.287109375
, 1.3994140625
▁the 1.3095703125
▁real 6.4921875
▁work 4.46875
▁lies 1.5908203125
▁ahead 0.048919677734375
▁in 1.6630859375
▁rig 5.234375
or 0.5244140625
ously 0.00011157989501953125
▁demonstr 4.5625
ating 4.887580871582031e-05
▁whether 5.2890625
▁OS 1.0693359375
C 0.00032067298889160156
- 0.0022830963134765625
4 0.0004334449768066406
3 0.00026297569274902344
▁significantly 7.37109375
▁impact 6.99609375
s 0.000995635986328125
▁surv 1.68359375
ival 0.003147125244140625
▁and 1.4853515625
▁quality 0.626953125
▁of 0.007610321044921875
▁life 0.0007119178771972656
▁for 0.5556640625
▁pan 0.49365234375
cre 4.2438507080078125e-05
atic 0.0012197494506835938
▁cancer 0.0020923614501953125
▁patients 0.004608154296875
. 0.06268310546875
▁Anal 4.39453125
yst 0.002132415771484375
s 0.0093536376953125
▁and 2.333984375
▁invest 0.457763671875
ors 0.0003733634948730469
▁will 0.95166015625
▁be 0.302490234375
▁eager 3.041015625
ly 0.07940673828125
▁await 1.0126953125
ing 0.00017249584197998047
▁the 0.41650390625
▁Ph 2.1484375
ase 1.52587890625e-05
▁ 0.0005664825439453125
3 0.0028171539306640625
▁data 1.5078125
▁before 5.56640625
▁passing 5.375
▁final 1.9951171875
▁judgment 0.235107421875
▁on 0.1544189453125
▁the 0.8681640625
▁drug 0.55126953125
' 0.265625
s 2.5987625122070312e-05
▁potential 0.27294921875
. 0.1097412109375
▁For 6.2890625
▁now 0.330810546875
, 0.0012111663818359375
▁optim 4.7890625
ism 0.0153961181640625
▁should 5.15625
▁remain 2.255859375
▁c 1.6494140625
aut 0.0030612945556640625
ious 0.0916748046875
. 1.1005859375
